X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 59 filers reported holding X4 PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 3.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $872,000 | -88.1% | 800,000 | -78.8% | 0.16% | -87.4% |
| Q2 2023 | $7,307,190 | +200.3% | 3,766,593 | +34.7% | 1.27% | +139.5% |
| Q1 2023 | $2,433,518 | +3.2% | 2,797,147 | +17.7% | 0.53% | -15.8% |
| Q4 2022 | $2,358,928 | +45.2% | 2,375,557 | +150.1% | 0.63% | +35.9% |
| Q3 2022 | $1,625,000 | – | 950,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |